Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,242 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07428538RecruitingPhase 3
Testing larsucosterol for severe alcohol-related hepatitis
This trial tests a new medicine called larsucosterol to see if it helps people with severe alcohol-related hepatitis (liver inflammation from heavy drinking). If you qualify, the study will monitor your safety and recovery over 90 days.
Birmingham, AlabamaAges 18 years+ - NCT07433179RecruitingPhase 1
Testing SEP-479 in healthy adults
This trial tests a new medication called SEP-479 in healthy volunteers to see how the body handles it. Volunteers receive either a single dose or multiple doses of the drug as part of early safety research.
MelbourneAges 21–60 - NCT07432958RecruitingPhase 2
Study of AP-472 with levodopa for Parkinson's motor fluctuations
This trial tests an experimental drug called AP-472, taken alongside your regular Parkinson's medications, to see if it can reduce the amount of "OFF" time you experience each day when symptoms return between doses of levodopa.
Little Rock, ArkansasAges 30–80 - NCT07426757RecruitingPhase 1
A study of PF-07994525 for advanced multiple myeloma
This trial tests an experimental drug, PF-07994525, for people with advanced multiple myeloma that has not responded to or could not tolerate at least 3 prior treatments. The goal is to see if it can help control the cancer.
Denver, ColoradoAges 18 years+ - NCT07430306RecruitingPhase 3
Study of anifrolumab for lupus patients not yet on strong treatments
This trial tests if a new drug called anifrolumab can help treat lupus in people who haven't taken strong medications like biologics or immunosuppressants before. It looks at overall disease activity and the chance to reduce steroid use.
Anniston, AlabamaAges 18–70 - NCT07434271RecruitingPhase 2
KH-001 for Lifelong Premature Ejaculation
This trial tests an investigational drug called KH-001 to see if it can help men with lifelong premature ejaculation last longer during intercourse. It focuses on men who consistently ejaculate very quickly (within a minute) and are in a stable relationship.
Botany, New South WalesAges 18–65 - NCT07427394RecruitingPhase 2
Camizestrant and atirmociclib for advanced breast cancer
This trial tests two experimental drugs—camizestrant and atirmociclib—for women with advanced ER-positive breast cancer that has worsened after prior treatment. The goal is to see if the combination is safe and tolerable.
St Louis, MissouriAges 18 years+ - NCT07429266RecruitingPhase 3
Study of sapablursen for phlebotomy-dependent polycythemia vera
This trial tests an investigational drug called sapablursen for people with polycythemia vera who still need frequent phlebotomies. The goal is to see if the drug can reduce the need for blood removal and help control the disease safely.
Miami, FloridaAges 18 years+ - NCT07432022RecruitingPhase 1/Phase 2
EMB-07 combo for aggressive B-cell lymphoma
This trial tests a new combination treatment for people with aggressive B-cell non-Hodgkin lymphoma, including those with relapsed/refractory disease or newly diagnosed high-risk cases. It aims to see if EMB-07 combined with other drugs is safe and effective.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07425821RecruitingPhase 1
Marburg Virus Vaccine Safety Trial
This trial tests a new vaccine to protect against Marburg virus, a rare but serious infection. The vaccine uses a weakened virus to teach your body to fight the Marburg virus, and researchers are checking if it is safe and how well it works.
Washington D.C., District of ColumbiaAges 18–50 - NCT06811831RecruitingEarly Phase 1
Mactientan for chest pain from small heart artery problems
This trial tests if mactientan, a blood vessel relaxer, can improve chest pain in people with coronary microvascular angina—where small heart arteries don't work right even though larger ones are clear. It aims to help those with ongoing angina symptoms.
Beijing, Beijing MunicipalityAges 18–75 - NCT06132035RecruitingPhase 1
CG-P5 eye drops for wet macular degeneration
This study tests a new eye drop (CG-P5) for people with wet age-related macular degeneration. It aims to see if the drops are safe and may help improve vision.
Manchester, ConnecticutAges 50 years+ - NCT07429721RecruitingEarly Phase 1
Testing QI-019A for multiple myeloma that came back
This trial tests a new drug called QI-019A for people whose multiple myeloma has returned or stopped responding to at least two prior treatments. The goal is to see if it is safe and if it can help control the disease.
Wuhan, HubeiAges 18 years+ - NCT07431359Recruiting
Mediterranean diet study for type 2 diabetes patients
This trial looks at what people with type 2 diabetes know about diet and how often they eat a Mediterranean diet. It aims to understand if this way of eating can help with diabetes management.
Peschiera del Garda, VeronaAges 18–80 - NCT07435142Recruiting
Urine-derived cells for corneal eye disease
This trial tests if using special cells from your own urine can help repair the inner layer of your cornea (the clear front part of your eye). It may be an option if you have damage to these cells and have already had at least one cornea transplant.
Jinan, ShandongAges 18–85 - NCT07433647Recruiting
Brain MRI changes in adults with cerebral palsy
This study looks at how the brain changes over time in people with cerebral palsy by reviewing MRI scans done as part of their regular care. It aims to understand brain health in adults with cerebral palsy.
New York, New YorkAges 18–80 - NCT07431892Recruiting
Pain after robotic vs. laparoscopic colon cancer surgery
This study compares pain levels after two types of minimally invasive colon cancer surgery: robotic and laparoscopic. It aims to see if one approach leads to less pain, which may help you recover more comfortably.
MadridAges 18 years+ - NCT07431983Recruiting
IBUS vs colonoscopy and enterography for UC and CD
This study compares a newer, possibly greener imaging method (IBUS) with standard colonoscopy and enterography for people with ulcerative colitis (UC) or Crohn's disease (CD). The goal is to see if IBUS is as helpful and produces less waste or carbon emissions.
Hyderabad, TelanganaAges 18–80 - NCT07427589Recruiting
New Heart Tests in Sleep Apnea
This study looks at how sleep apnea affects your heart and blood vessels over time. It uses a sleep study and heart tests to see if certain measurements can predict heart health changes.
AntwerpAges 18 years+ - NCT07428993RecruitingPhase 2
CAR T-Cell Therapy for High-Risk Osteosarcoma
This trial tests a new type of cell therapy called B7-H3 CAR T cells for children and young adults with high-risk osteosarcoma that hasn't spread or worsened after standard chemotherapy. The treatment uses your own immune cells that are modified to attack a protein (B7-H3) found on cancer cells.
Memphis, TennesseeAges Up to 21 years - NCT07430319Recruiting
Real-life study of guselkumab dosing intervals
This trial is for people with skin psoriasis who are already taking guselkumab (Tremfya) and have their shots spaced 9 weeks or longer apart. Researchers will see how well the skin is controlled with this longer interval.
Nice, Alpes MaritimesAges 18 years+ - NCT07434518Recruiting
Study of adebrelimab for advanced small cell lung cancer
This study looks at how well adebrelimab works and how safe it is in real-world settings for people with advanced small cell lung cancer that has spread. It may help doctors understand if this treatment is a good option for patients like you.
ShanghaiAges 18–100 - NCT07426276Enrolling by invitation
Parent training plus speech therapy for speech development disorder
This study tests whether combining parent training with speech therapy helps children with speech development disorder more than speech therapy alone. It is for children aged 3 to 5 who have been diagnosed with a developmental language disorder.
Messina, MessinaAges 3–5 - NCT07434154Recruiting
Comparing oxidative stress in type 1 diabetes and LADA
This study looks at oxidative stress—a type of cell damage—in people with type 1 diabetes or LADA. It may help explain how these conditions affect the body and guide future care.
Pavia, PaviaAges 18–75
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,242 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.